Clinical Trials Logo
  1. Home
  2. Anhedonia
  3. NCT06270433

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

Anhedonia Clinical Trial

Official title:
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder: a Multicentre, Open-label, Parallel-group, Randomised Controlled Trial

Clinical Trial Summary

The purpose of this study is to evaluate efficacy and safety of toludesvenlafaxine hydrochloride sustained-release tablets in the treatment of anhedonia in patients with major depression disorder compared to desvenlafaxine succinate sustained-release tablets, to provide evidence-based basis for clinical rational drug use.

Clinical Trial Description

The study included 80 patients with major depression disorder (aged 18 to 65 years) who meet the diagnostic criteria for depression in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Eligible patients were randomly assigned (1:1) to 8-week treatment with toludesvenlafaxine hydrochloride sustained-release tablets (n=40) or desvenlafaxine succinate sustained-release tablets(n=40), followed up at period of enrollment as baseline and at the end of 2th, 4th and 8th weeks. Adverse events were recorded. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06270433
Study type Interventional
Source Jiangsu Province Nanjing Brain Hospital
Contact
Status Recruiting
Phase N/A
Start date February 19, 2024
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Enrolling by invitation NCT06035562 - Promoting Positive Emotional Functioning in Police and Military Populations N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Completed NCT03043560 - Study to Treat Major Depressive Disorder With a New Medication Phase 2
Withdrawn NCT05507385 - Imagine a Brighter Future: An Intervention to Improve Positive Emotions in Young People N/A
Completed NCT05383248 - Computational Cognitive Training To Boost Reward Responsiveness In Anhedonic Patients N/A
Suspended NCT03715400 - Mobile Virtual Positive Experiences for Anhedonia N/A
Recruiting NCT05240352 - Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression N/A
Recruiting NCT03915613 - Brain Insulin Resistance in Mood Disorders Phase 1/Phase 2
Completed NCT04121091 - Pramipexole to Target "Anhedonic Depression" Phase 2
Completed NCT03939676 - Evaluating Motivation and Reward Mechanisms and Brain Substrates in Adults With Obesity
Enrolling by invitation NCT06285474 - Investigating LIFUP in Anhedonic Depression N/A
Recruiting NCT05870501 - Synaptic Imaging and Network Activity in Treatment Resistant Depression N/A
Active, not recruiting NCT03848715 - Sleep and Healthy Aging Research on Depression for Younger Women Phase 1
Completed NCT05165394 - Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD Phase 2
Completed NCT04647019 - The Effects of Wild Blueberries on Depressive Symptoms in Young Adults N/A
Recruiting NCT06075771 - Dopaminergic Therapy for Anhedonia - 2 Phase 4
Completed NCT02958228 - The Effect of Computerized Cognitive Training on Mood and Thinking Style Amongst Patients in Inpatient Settings N/A
Recruiting NCT05991713 - Geolocation Positional System (GPS) Experience N/A
Completed NCT05084924 - Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia N/A